ABCL vs ABSI Stock Comparison
ABCL currently leads ABSI in this stock comparison, with AIQ scores of 64 vs 53. The clearest difference is quality.
What is the main difference between ABCL and ABSI?
ABCL leads the current stock comparison as AbCellera Biologics Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
AbCellera Biologics Inc. vs Absci Corporation
ABCL leads
ABCL leads by 11 AIQ points, primarily on Quality and Momentum. Wall Street currently favors ABSI on target upside.
Competitive: 4 of 5 evidence groups support ABCL, and its current signal state is conflicted.
AbCellera Biologics Inc.
Absci Corporation
The Algovestiq AIQ Score currently favors ABCL over ABSI, 64 versus 53 as of Nov 15, 2026. ABCL's advantage is driven primarily by stronger quality and momentum. ABCL also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors ABSI. 4 of 5 covered evidence groups favor ABCL today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. ABCL lead: Stable — the AIQ differential has held near 11 points over 30 sessions.
Compare AbCellera Biologics Inc. and Absci Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare ABCL and ABSI against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality61 vs 26ABCL +35
- Momentum89 vs 85ABCL +4
- Risk Resilience34 vs 30ABCL +4
4 of 5 evidence groups favor ABCL. ABCL’s edge is concentrated in quality and momentum.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +2
No signal started or stopped since the prior session; its 4 active signals are unchanged.
Largest factor move: Quality -2, not enough on its own to move the overall score.
New signals
- TSI Bearish Crossover — bearish, momentum, short horizon
ABCL's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — ABCL and ABSI both carry a full feed there.
The central trade-off
ABCL (AbCellera Biologics Inc.): the stronger current systematic profile, led by quality and momentum.
ABSI (Absci Corporation): the counter-case, on analyst expectations — but at materially higher volatility, 126.6% against 88.8%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
ABCLABCL on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
ABCLABCL on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
ABCLABCL on the Momentum factor, by 4 points.
Lower downside
ABCLABCL on Risk Resilience, by 4 points.
Analyst upside
ABSIABSI on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors ABCL, analyst targets favor ABSI. That disagreement is the most useful thing on this page.
| Measure | ABCL | ABSI | Note |
|---|---|---|---|
| Implied upside to target | +50.9% | +71.6% | ABSI has more room |
| Target dispersion | +46.2% | +6.9% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 13 | 12 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 5 covered evidence groups favor ABCL. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | ABCL | 64 vs 53 |
| Fundamentals | ABCLon balance | revenue growth 162.7% vs -4.4%; EPS growth 27.8% vs 9.5%; TTM ROE -3.8% vs -15.2%; gross margin 75.6% vs -26.5%; operating margin -298% vs -91.6% — ABCL takes 4 of 5 decided legs, not all of them |
| Valuation | Not covered | Not covered |
| Technicals | ABCL | Price vs 50-day -6.9% vs -12.5%; vs 200-day 58.8% vs 23.7% |
| Risk Resilience | ABCL | Risk Resilience 34 vs 30 |
| Analyst expectations | ABSI | Target upside 50.9% vs 71.6% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ABCL and ABSI and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is moderate at 11 points.
- 4 of 5 covered evidence groups point the same way. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ABCL.
How the comparison changed
120 daily snapshots · May 27 – Nov 13ABCL lead: Stable — the AIQ differential has held near 11 points over 30 sessions.
- Today
- ABCL +11
- 64 vs 53
- 7 sessions ago
- ABCL +7
- 62 vs 55
- 30 sessions ago
- ABCL +9
- 62 vs 53
- 90 sessions ago
- ABCL +7
- 64 vs 57
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 2 bearish / 1 neutral, conflicted
No signal that the other name lacks.
2 bullish / 3 bearish / 1 neutral, conflicted
Only ABSI
- Accumulation Pattern — bullish, volume, medium horizon (1.30x)
- TSI Bearish Crossover — bearish, momentum, short horizon
Both carry 4 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, Beta Spike Warning, MACD Histogram Expanding Bearish.
ABCL leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -1.12%, AIQ +1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -7.5%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1ABSI closes the Quality gap — currently 35 points behind, the largest single contributor to ABCL's edge.
- 2ABSI's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
- 3ABCL's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
ABCL leads on balance| Metric | ABCL | ABSI |
|---|---|---|
| Revenue growth (YoY) | 162.7% | -4.4% |
| EPS growth (YoY) | 27.8% | 9.5% |
| Gross margin | 75.6% | -26.5% |
| Operating margin | -298% | -91.6% |
| Return on equity (TTM) | -3.8% | -15.2% |
| Debt to equity | 0.13 | 0.02 |
Performance
ABCL leads 5 of 6 windows| Metric | ABCL | ABSI |
|---|---|---|
| 1 week (5 sessions) | -3.3% | -16.9% |
| 1 month (20 sessions) | -2.6% | 2.4% |
| 3 months (63 sessions) | 2.6% | -8.5% |
| 6 months (126 sessions) | 180.9% | 64.7% |
| Year to date | 236% | 142.1% |
| 1 year (252 sessions) | 189.4% | 148.5% |
Technicals
ABCL has the stronger structure| Metric | ABCL | ABSI |
|---|---|---|
| RSI (14) | 45.2 | 42 |
| ADX (14) | 11.9 | 13.8 |
| Price vs 50-day | -6.9% | -12.5% |
| Price vs 200-day | 58.8% | 23.7% |
| Volatility (1M, annualized) | 88.8% | 126.6% |
Risk
ABCL is the more resilient| Metric | ABCL | ABSI |
|---|---|---|
| Beta | 2.42 | 3.28 |
| Sharpe ratio | 1.73 | 1.58 |
| Sortino ratio | 3.02 | 2.74 |
| Max drawdown | -40.1% | -42.8% |
| Current drawdown | -22.5% | -30.2% |
| Annualized volatility | 85.3% | 104.2% |
| Value at risk (95%) | -7.1% | -8.2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, ABCL or ABSI?
On the Algovestiq AIQ Score, ABCL is the stronger of the two as of Nov 15, 2026, scoring 64 against ABSI's 53. The edge comes from quality and momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is ABCL or ABSI the better buy right now?
ABCL carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor ABCL over ABSI?
The composite weights Quality, Value, Momentum and Risk Resilience. ABCL leads Quality by 35 points; ABCL leads Momentum by 4 points; ABCL leads Risk Resilience by 4 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, ABCL or ABSI?
Analyst price targets imply +50.9% upside for ABCL and +71.6% for ABSI, so the Street currently favors ABSI. That points the opposite way to the AIQ Score, which favors ABCL. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, ABCL or ABSI?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, ABCL or ABSI?
ABCL on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, ABCL or ABSI?
ABCL on the Momentum factor, by 4 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, ABCL or ABSI?
ABCL is the more resilient of the two, so the other name carries the higher downside risk. ABCL on Risk Resilience, by 4 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is ABCL more profitable than ABSI?
The profitability evidence is mixed: gross margin 75.6% vs -26.5%; operating margin -298% vs -91.6%; ttm roe -3.8% vs -15.2%. ABCL leads on two measures and ABSI on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is ABCL's lead over ABSI getting stronger or weaker?
ABCL lead: Stable — the AIQ differential has held near 11 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the ABCL vs ABSI verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ABSI closes the Quality gap — currently 35 points behind, the largest single contributor to ABCL's edge; ABSI's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; ABCL's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about ABCL and ABSI?
ABCL: 1 bullish / 2 bearish / 1 neutral, conflicted. ABSI: 2 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ABCL is Golden Cross Active (bullish, long horizon). On ABSI it is Golden Cross Active (bullish, long horizon).
Compare ABCL and ABSI with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.